‘Chief bluebird’ Nick Leschly nails a rich $24M compensation bounty as biotech packages soar
Biotech execs reaped a rich harvest of compensation packages for 2018, and as of now bluebird bio CEO Nick Leschly holds the top mark on pay.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.